Loading...
In 1928, Alexander Fleming discovered penicillin, and by 1945 it was saving thousands of lives in WWII field hospitals. That same year, Fleming warned in his Nobel lecture: bacteria would develop resistance if antibiotics were used carelessly. He was right within four years. By 1950, 40% of hospital Staphylococcus strains resisted penicillin. Doctors switched to methicillin in 1961. MRSA appeared that same year. The pattern was relentless. Each new antibiotic created a selection pressure that rewarded the tiny fraction of bacteria carrying resistance genes. Those survivors multiplied, passing resistance not just to offspring but horizontally to other species through plasmid transfer — a trick unique to bacteria that accelerates the race enormously. By 2000, vancomycin was the 'antibioti...
Popular framing: Antibiotic resistance is caused by people misusing antibiotics — not finishing courses, demanding unnecessary prescriptions — and can be fixed by better public education and stricter prescribing standards. It's not just 'carelessness'; the Red Queen race is an inevitable physical consequence of using a chemical to kill a replicating organism.
Structural analysis: Resistance is the output of a reinforcing feedback loop embedded in three interlocking systems: evolutionary biology (selection pressure is unavoidable), economic incentives (agriculture and pharma both profit from overuse or abandon the field entirely), and collective action failure (individual rational behavior — use antibiotics when available — produces irrational collective outcomes). The loop has no natural dampener; every intervention that reduces one input (human medicine) is offset by another (agriculture, developing-world access pressure). The 'Lindy Effect' of bacteria—they have been around for billions of years and have 'seen' every type of chemical attack before. Our drugs are 'new,' but their defense mechanisms are 'old' and robust.
The popular framing locates agency in individuals while the structural problem is a systems-level tragedy of the commons with no market mechanism for correction. This gap matters because it produces interventions (awareness campaigns, prescribing guidelines) targeted at the least leveraged nodes in the system, while high-leverage nodes — agricultural use regulation, antibiotic market restructuring, horizontal gene transfer as an accelerant — receive inadequate attention and political will.
